Technology | April 29, 2015

Extension of "Elements" strategy completes portfolio of automated, indication-specific planning tools for radiosurgery/SBRT

April 29, 2015 — Brainlab expanded on its “Elements” strategy for treatment of brain and spine tumors with the introduction of automated stereotactic radiosurgery (SRS) planning tools. Announced at the third European Society for Therapeutic Radiology and Oncology (ESTRO) Forum in Barcelona, Spain, the SRS tools enable on-the-fly generation of consistent treatment plans for volumetric arc therapy (VMAT) delivery.

Introduced in 2013, the Elements strategy uses indication-specific focused software applications aimed at enhancing the workflow for difficult to treat indications in the brain and spine.

Previously introduced Elements for cranial radiosurgery have focused on enhancing image fusion, distortion correction of various magnetic resonance imaging (MRI) sequences, interactive segmentation of tumors and vascular structures, fibertracking, dose review and automatic segmentation of critical structures. Adaptive Hybrid Surgery tools have helped to simulate and evaluate the feasibility of radiosurgery treatments at different resection levels during surgery.

Radiosurgery treatment planning for cranial indications, however, remains a manual iterative process that is highly user-dependent. One of the new Elements tools Brainlab introduced automatically generates highly conformal treatment plans for a variety of indications, locations, sizes, shapes and fractionation schemes, all with the click of a button. Instead of choosing between different delivery techniques, the Element algorithm produces a Meaningful Use (MU)-optimized plan for delivery as volumetric, intensity modulated arc. For treatment of spherical targets, such as singular metastases, or small functional targets, such as trigeminal neuralgia, another new Element has been designed around the challenges of these specific treatments.

Spinal radiosurgery represents another challenging treatment with multiple complex and manual steps. In addition to streamlining the fusion and segmentation steps, another VMAT-based automatic planning Element for spinal SRS can generate complex yet highly conformal plans. This tool is specifically designed to address the visualization and optimization requirements for stereotactic treatments for spine indications.

For more information: www.brainlab.com


Related Content

News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Subscribe Now